(Q50908717)

English

Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial.

scientific article published in January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

6

object named as

R M Califf

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

author name string

J C Blankenship

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

A S Hellkamp

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

F V Aguirre

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

S L Demko

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

81

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

36-40

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

Vascular complications of cardiac catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Vascular complications of percutaneous femoral cardiac interventions. Incidence and operative repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Peripheral vascular complications from percutaneous transluminal coronary angioplasty: a comparison with transfemoral cardiac catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Influence of arterial access sites and interventional procedures on vascular complications after cardiac catheterizations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Vascular complications after balloon and new device angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Predictors of groin complications after balloon and new-device coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900796-0

7 January 2021

Identifiers

10.1016/S0002-9149(97)00796-0

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9462603

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50908717&oldid=2104971905"